vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Safehold Inc. (SAFE). Click either name above to swap in a different company.

Safehold Inc. is the larger business by last-quarter revenue ($97.9M vs $75.1M, roughly 1.3× MEDIFAST INC). On growth, Safehold Inc. posted the faster year-over-year revenue change (6.5% vs -36.9%). Over the past eight quarters, Safehold Inc.'s revenue compounded faster (2.5% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

SAFE Investment Company Limited is a Chinese sovereign wealth fund based in Hong Kong.

MED vs SAFE — Head-to-Head

Bigger by revenue
SAFE
SAFE
1.3× larger
SAFE
$97.9M
$75.1M
MED
Growing faster (revenue YoY)
SAFE
SAFE
+43.4% gap
SAFE
6.5%
-36.9%
MED
Faster 2-yr revenue CAGR
SAFE
SAFE
Annualised
SAFE
2.5%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
SAFE
SAFE
Revenue
$75.1M
$97.9M
Net Profit
$27.9M
Gross Margin
69.4%
98.6%
Operating Margin
-10.4%
27.4%
Net Margin
28.5%
Revenue YoY
-36.9%
6.5%
Net Profit YoY
7.1%
EPS (diluted)
$-1.64
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
SAFE
SAFE
Q4 25
$75.1M
$97.9M
Q3 25
$89.4M
$96.2M
Q2 25
$105.6M
$93.8M
Q1 25
$115.7M
$97.7M
Q4 24
$119.0M
$91.9M
Q3 24
$140.2M
$90.7M
Q2 24
$168.6M
$89.9M
Q1 24
$174.7M
$93.2M
Net Profit
MED
MED
SAFE
SAFE
Q4 25
$27.9M
Q3 25
$-2.3M
$29.3M
Q2 25
$2.5M
$27.9M
Q1 25
$-772.0K
$29.4M
Q4 24
$26.0M
Q3 24
$1.1M
$19.3M
Q2 24
$-8.2M
$29.7M
Q1 24
$8.3M
$30.7M
Gross Margin
MED
MED
SAFE
SAFE
Q4 25
69.4%
98.6%
Q3 25
69.5%
98.5%
Q2 25
72.6%
99.1%
Q1 25
72.8%
98.8%
Q4 24
74.1%
98.8%
Q3 24
75.4%
98.8%
Q2 24
73.2%
98.8%
Q1 24
72.8%
98.8%
Operating Margin
MED
MED
SAFE
SAFE
Q4 25
-10.4%
27.4%
Q3 25
-4.6%
25.9%
Q2 25
-1.0%
25.5%
Q1 25
-1.1%
25.9%
Q4 24
0.6%
24.6%
Q3 24
1.5%
17.5%
Q2 24
-4.7%
26.7%
Q1 24
4.5%
26.4%
Net Margin
MED
MED
SAFE
SAFE
Q4 25
28.5%
Q3 25
-2.5%
30.5%
Q2 25
2.3%
29.8%
Q1 25
-0.7%
30.1%
Q4 24
28.3%
Q3 24
0.8%
21.3%
Q2 24
-4.8%
33.0%
Q1 24
4.8%
33.0%
EPS (diluted)
MED
MED
SAFE
SAFE
Q4 25
$-1.64
$0.38
Q3 25
$-0.21
$0.41
Q2 25
$0.22
$0.39
Q1 25
$-0.07
$0.41
Q4 24
$0.08
$0.36
Q3 24
$0.10
$0.27
Q2 24
$-0.75
$0.42
Q1 24
$0.76
$0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
SAFE
SAFE
Cash + ST InvestmentsLiquidity on hand
$167.3M
$21.7M
Total DebtLower is stronger
$4.6B
Stockholders' EquityBook value
$198.9M
$2.4B
Total Assets
$248.0M
$7.2B
Debt / EquityLower = less leverage
1.90×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
SAFE
SAFE
Q4 25
$167.3M
$21.7M
Q3 25
$173.5M
$12.1M
Q2 25
$162.7M
$13.9M
Q1 25
$164.6M
$17.3M
Q4 24
$162.3M
$8.3M
Q3 24
$170.0M
$15.6M
Q2 24
$163.5M
$13.4M
Q1 24
$156.4M
$11.3M
Total Debt
MED
MED
SAFE
SAFE
Q4 25
$4.6B
Q3 25
$4.5B
Q2 25
$4.4B
Q1 25
$4.3B
Q4 24
$4.3B
Q3 24
$4.3B
Q2 24
$4.2B
Q1 24
$4.1B
Stockholders' Equity
MED
MED
SAFE
SAFE
Q4 25
$198.9M
$2.4B
Q3 25
$214.7M
$2.4B
Q2 25
$216.0M
$2.4B
Q1 25
$211.0M
$2.4B
Q4 24
$210.1M
$2.3B
Q3 24
$207.3M
$2.3B
Q2 24
$205.3M
$2.3B
Q1 24
$211.0M
$2.3B
Total Assets
MED
MED
SAFE
SAFE
Q4 25
$248.0M
$7.2B
Q3 25
$268.2M
$7.1B
Q2 25
$269.3M
$7.1B
Q1 25
$280.0M
$6.9B
Q4 24
$284.2M
$6.9B
Q3 24
$291.2M
$6.8B
Q2 24
$293.5M
$6.8B
Q1 24
$302.8M
$6.7B
Debt / Equity
MED
MED
SAFE
SAFE
Q4 25
1.90×
Q3 25
1.89×
Q2 25
1.87×
Q1 25
1.85×
Q4 24
1.84×
Q3 24
1.88×
Q2 24
1.81×
Q1 24
1.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
SAFE
SAFE
Operating Cash FlowLast quarter
$-5.3M
$47.8M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
1.72×
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
SAFE
SAFE
Q4 25
$-5.3M
$47.8M
Q3 25
$12.1M
$-1.4M
Q2 25
$-3.4M
$28.0M
Q1 25
$3.4M
$8.9M
Q4 24
$-4.9M
$37.9M
Q3 24
$9.1M
$8.3M
Q2 24
$13.1M
$24.8M
Q1 24
$7.3M
$-3.1M
Free Cash Flow
MED
MED
SAFE
SAFE
Q4 25
$-6.6M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
Q1 24
$5.4M
FCF Margin
MED
MED
SAFE
SAFE
Q4 25
-8.8%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Q1 24
3.1%
Capex Intensity
MED
MED
SAFE
SAFE
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
1.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
MED
MED
SAFE
SAFE
Q4 25
1.72×
Q3 25
-0.05×
Q2 25
-1.36×
1.00×
Q1 25
0.30×
Q4 24
1.45×
Q3 24
8.04×
0.43×
Q2 24
0.83×
Q1 24
0.88×
-0.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

SAFE
SAFE

Equity Method Investment Nonconsolidated Investee Or Group Of Investees$60.3M62%
Other$33.7M34%
Stabilized Properties$3.8M4%

Related Comparisons